Translating scientific breakthroughs into clinical practice

Pricing, reimbursement and regulatory frameworks continue to complicate the journey from biomedical breakthrough to clinical practice. As US policy reshapes global investment incentives and China rapidly strengthens its biotech ecosystem, Europe faces a critical challenge: creating the conditions for medical innovation to thrive while ensuring that scientific advancements translate into timely, affordable treatments for patients who need them most.